BIOG-B:STO
BioGaia AB
116,80Â SEK
arrow_upward
+1,21%(+1,40) 1 p
9. okt, 17:29:57 GMT +2 · SEK
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse BIOG-B põhistatistika genereerimine…
Ava
116,20Â SEK
Kõrge
117,90Â SEK
Madal
116,00Â SEK
Turu kapit.
11,50Â mld
Keskm. maht
162,09Â tuh
Maht
58,09Â tuh
52 näd kõrgeim
136,30Â SEK
52 näd madalaim
96,20Â SEK
Käibivad aktsiad
98,50Â mln
Töötajate arv
251
Ava
116,20Â SEK
Kõrge
117,90Â SEK
Madal
116,00Â SEK
Turu kapit.
11,50Â mld
Keskm. maht
162,09Â tuh
Maht
58,09Â tuh
52 näd kõrgeim
136,30Â SEK
52 näd madalaim
96,20Â SEK
Käibivad aktsiad
98,50Â mln
Töötajate arv
251
Uudised
Veebiallikatest ja uudistepartneritelt
TipRanks
·
1 päeva eest
BioGaia Sets October 22 Date for Q3 2026 Results and Investor Briefing
Profiil
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Teave üksuse BioGaia AB kohta